Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

39.20 -1.31 (-3.23%)
Streaming Delayed Price Updated: 11:52 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,038,348
Open 40.12
Bid (Size) 39.17 (300)
Ask (Size) 39.24 (200)
Prev. Close 40.51
Today's Range 38.96 - 40.91
52wk Range 22.28 - 55.20
Shares Outstanding 391,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Moderna: Stock to Avoid or Bad News Buy? ↗
Moderna stock was a highflier in early pandemic days as sales of its coronavirus vaccine soared. 
Via The Motley Fool
News headline image
FDA Stuns Moderna with Refusal to Review Flu Vaccine, Sending Shares Tumbling 3.5%
Shares of Moderna, Inc. (NASDAQ: MRNA) fell 3.5% on February 12, 2026, as investors continued to digest the fallout from a rare and unexpected regulatory setback. The U.S. Food and Drug Administration... 
Via MarketMinute
Topics Earnings

Performance

YTD
+27.0%
+27.0%
1 Month
+15.8%
+15.8%
3 Month
+46.8%
+46.8%
6 Month
+45.8%
+45.8%
1 Year
+26.7%
+26.7%

More News

Read More
News headline image
The Bioelectronic Frontier: A Deep-Dive into NovoCure’s Multi-Indication Transformation
Via Finterra
Topics Initial Public Offering Intellectual Property
AI Agents and the Jobs Report Jitter: A Wall Street Balancing Act ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
What To Expect From Moderna’s (MRNA) Q4 Earnings
Via StockStory
Topics Artificial Intelligence
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Gapping S&P500 stocks in Wednesday's session ↗
Via Chartmill
News headline image
Moderna (MRNA) Deep Dive: Navigating Regulatory Blows and the Pivot to Oncology
Via Finterra
Topics Artificial Intelligence Initial Public Offering Intellectual Property
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Nasdaq, S&P 500 Futures Rise Ahead Of Delayed Jobs Data: Why NVDA, WBD, HOOD, MRNA, ASTS Are On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence ETFs Stocks
News headline image
Why Did Moderna Stock Tumble Nearly 10% After Hours Today? ↗
Via Stocktwits
News headline image
Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
Via ACCESS Newswire
News headline image
1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell ↗
Via The Motley Fool
Topics Intellectual Property
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
News headline image
Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico
Via ACCESS Newswire
News headline image
Should You Buy Moderna Before Feb. 13? ↗
Via The Motley Fool
News headline image
Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
Via Finterra
Topics ETFs Economy Initial Public Offering
News headline image
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
From Equity Insider
Via GlobeNewswire
News headline image
Tom Gardner's 2026 Outlook: Volatility, Government Scrutiny, and Two AI-Adjacent Stocks ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc.
From Defiance ETFs
Via GlobeNewswire
Gapping S&P500 stocks in Monday's session ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Dr. David Berman to Join Moderna as Chief Development Officer
Via ACCESS Newswire
News headline image
Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)
Via ACCESS Newswire
News headline image
3 ETFs Catapulting Beyond the S&P to Start the Year ↗
Via MarketBeat
Topics ETFs Stocks

Frequently Asked Questions

Is Moderna, Inc. - Common Stock publicly traded?
Yes, Moderna, Inc. - Common Stock is publicly traded.
What exchange does Moderna, Inc. - Common Stock trade on?
Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moderna, Inc. - Common Stock?
The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
What is the current price of Moderna, Inc. - Common Stock?
The current price of Moderna, Inc. - Common Stock is 39.20
When was Moderna, Inc. - Common Stock last traded?
The last trade of Moderna, Inc. - Common Stock was at 02/12/26 11:52 AM ET
What is the market capitalization of Moderna, Inc. - Common Stock?
The market capitalization of Moderna, Inc. - Common Stock is 15.33B
How many shares of Moderna, Inc. - Common Stock are outstanding?
Moderna, Inc. - Common Stock has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.